SCHEMBL18753391

SCHEMBL18753391

O=C(c1ccc(N[SH](=O)=O)c(C(F)(F)F)c1)N1CCN(C(=O)c2c(F)cccc2F)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.48
▸ LMNA P02545 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ EPHX2 P34913 3/20 0.43
▸ HPGDS O60760 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753448 0.87 LMNA (0.51) ALDH1A1LMNATSHRCYP1A2CYP2C9
SCHEMBL18753740 0.84 LMNA (0.48) ALDH1A1LMNATSHRCYP1A2CYP2C9
SCHEMBL21650827 0.83 ALDH1A1 (0.47) ALDH1A1LMNATSHRCYP1A2CYP2C9
SCHEMBL18753793 0.83 CYP2D6 (0.47) TSHRCYP1A2CYP2C9CYP2C19EPHX2
SCHEMBL18753362 0.81 PKM (0.52) ALDH1A1CYP2C9EPHX2KMT2AMEN1
SCHEMBL19561892 0.80 ALDH1A1 (0.53) ALDH1A1LMNATSHRCYP1A2CYP2C9
SCHEMBL19561834 0.80 LMNA (0.45) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL18753865 0.78 LMNA (0.58) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL19562111 0.77 CYP2D6 (0.43) ALDH1A1TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL18753861 0.77 MGLL (0.45) CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback